• Info
  • Insider Ownership

Insider Trading & Ownership of Daniel B. Soland

Location
Emeryville, CA
Summary
The estimated net worth of Daniel B. Soland is at least $961,891 dollars as of 02 Jun 2025. Daniel B. Soland is the Director of ACADIA PHARMACEUTICALS INC and owns shares of ACADIA PHARMACEUTICALS INC (ACAD) stock worth about $927.1K. Daniel B. Soland is the Director of DBV Technologies S.A. and owns shares of DBV Technologies S.A. (DBVT) stock worth about $34.8K.
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Daniel B. Soland and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Daniel B. Soland has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $961,891.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ACADIA PHARMACEUTICALS INC ($927,091).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Daniel B. Soland

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ACAD ACADIA PHARMACEUTICALS INC Director $927,091 29 May 2025
DBVT, DBVTF DBV Technologies S.A. Director $34,800 01 Aug 2023
IDRA IDERA PHARMACEUTICALS, INC. Chief Operating Officer 06 Jul 2022
KALV KalVista Pharmaceuticals, Inc. Director 30 Sep 2021

Insider Transactions Reported by Daniel B. Soland:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.